Why is a $1,575-a-month drug approved and a $7 one isn't? - The Globe and Mail
Expensive Drugs - American Academy of Ophthalmology
3 Drugs for an Eye Disease, With Big Price Gaps, Are Found to Be Equals for Many - The New York Times
Rule on Avastin for Eyes Could Cost Medicare and Patients - The New York Times
An effective eye drug is available for $50. But many doctors choose a $2,000 alternative. - The Washington Post
AVASTIN (bevacizumab) injection, for intravenous use - South Delhi Pharma
Lucentis, Avastin Found Equally Useful at Treating AMD - Haaretz Com - Haaretz.com
Novartis Asks Court to Bar U.K. From Prescribing Lucentis Rival - WSJ
Fake Avastin cancer drug issued to doctors - CBS News
Medicare Payments for Drugs Used To Treat Wet Age Related Macular Degeneration (OEI-03-10-00360; 04/12)
NHS wins legal fight against pharma firms over sight-loss drug | NHS | The Guardian
Study: Using Avastin over Lucentis could save $18B - MM+M - Medical Marketing and Media
Pfizer Announces Launch of Three Biosimilar Cancer Treatments - MPR
COVID-19: EMA empfiehlt langwirksame Antikörperkombination...
Avastin Prices, Coupons, Copay & Patient Assistance - Drugs.com
Cost of Treatment May Influence Doctors - The New York Times
Genentech pays doctors to prescribe its newer more expensive drug, which costs $2,000/dose vs. older, cheaper, equally-effective drug Avastin ($50/ dose). Cost to taxpayers: $1 B-billion/A YEAR : r/news
France aims to save big bucks by subbing unapproved Avastin for eye drug Lucentis | Fierce Pharma
Avastin injection for Eye | Anti Vegf | Eye Solutions
AVASTIN CLINICAL PHARMACOLOGY DRUG MONOGRAPH
Roche, Novartis protest moves in EU to pay for off-label Avastin | Fierce Pharma
